Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

NCT01946165 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Abiraterone Acetate
DRUG: Prednisone
DRUG: Enzalutamide
DRUG: LHRHa

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]